53
Views
0
CrossRef citations to date
0
Altmetric
Brief Report

Optociliary shunt vessels in multiple sclerosis

ORCID Icon &
Received 10 Feb 2023, Accepted 03 May 2024, Published online: 22 May 2024

References

  • Sowka JW, Kabat AG. Collateral damage. [Internet] Review of Optometry; [cited 6 October 2019] 2014. Available from: https://www.reviewofoptometry.com/article/collateral-damage.
  • Miller NR, Newman NJ, Biousse V, et al. Walsh and hoyt’s clinical neuro-ophthalmology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2005. p. 227. ISBN: 0-7817-4814-3.
  • Ling JD, Chao D, Al Zubidi N, et al. Big red flags in neuro-ophthalmology. Can J Ophthalmol. 2013;48(1):3–7. doi: 10.1016/j.jcjo.2012.08.016.
  • Masuyama Y, Kodama Y, Matsuura Y, et al. Clinical studies on the occurrence and the pathogenesis of optociliary veins. J Clin Neuroophthalmol. 1990;10(1):1–8.
  • Miller NR, Solomon S. Retinochoroidal (optociliary) shunt veins, blindness and optic atrophy: a non-specific sign of chronic optic nerve compression. Aust N Z J Ophthalmol. 1991;19(2):105–109. doi: 10.1111/j.1442-9071.1991.tb00636.x.
  • Lee JJ, Yap EY. Optociliary shunt vessels in diabetes mellitus. Singapore Med J. 2004;45(4):166–169.
  • Friedman SM. Optociliary venous anastomosis after ­radial optic neurotomy for Central retinal vein occlusion. Ophthalmic Surg Lasers Imaging Retina. 2003;34(4):315–317. doi: 10.3928/1542-8877-20030701-10.
  • Anderson SF, Townsend JC, Selvin GJ, et al. Congenital optociliary shunt vessels. J Am Optom Assoc. 1991;62(2):109–115.
  • Giuffrè G, Palumbo C, Randazzo-Papa G. Optociliary veins and Central retinal vein occlusion. Br J Ophthalmol. 1993;77(12):774–777. doi: 10.1136/bjo.77.12.774.
  • Eggers HM, Sanders MD. Acquired optociliary shunt vessels in papilloedema. Br J Ophthalmol. 1980;64(4):267–271. doi: 10.1136/bjo.64.4.267.
  • Ataş F, Saatci AO. Optociliary shunt vessels or neovascularisation of the optic disc: fluorescein angiography versus optical coherence tomography angiography. Neuroophthalmology. 2022;46(5):339–342. doi: 10.1080/01658107.2022.2033796.
  • Moura FC, Fortini I. Optociliary shunt vessels: role in diagnosis and treatment of atypical pseudotumor cerebri. Neuroophthalmology. 2017;41(4):224–226. doi: 10.1080/01658107.2017.1304967.
  • Fuller JJ, Mason JO, 3rd, White MF, Jr, et al. Retinochoroidal collateral veins protect against anterior segment neovascularization after central retinal vein occlusion. Arch Ophthalmol. 2003;121(3):332–336. doi: 10.1001/archopht.121.3.332.
  • Thompson AJ, Baranzini SE, Geurts J, et al. Multiple sclerosis. Lancet. 2018;391(10130):1622–1636. doi: 10.1016/S0140-6736(18)30481-1.
  • Travers BS, Tsang BK, Barton JL. Multiple sclerosis: diagnosis, disease-modifying therapy and prognosis. Aust J Gen Pract. 2022;51(4):199–206. doi: 10.31128/AJGP-07-21-6103.
  • Klineova S, Lublin FD. Clinical course of multiple sclerosis. Cold Spring Harb Perspect Med. 2018;8(9):a028928. doi: 10.1101/cshperspect.a028928.
  • Yamout BI, Alroughani R. Multiple sclerosis. Semin Neurol. 2018;38(2):212–225. doi: 10.1055/s-0038-1649502.
  • Miller NR, Johnson LN, Bakaeva T, et al. Is neuroretinitis associated with multiple sclerosis? J Neuroophthalmol. 2022;42(1):126–130. doi: 10.1097/WNO.0000000000001374.
  • Cennamo G, Romano MR, Vecchio EC, et al. Anatomical and functional retinal changes in multiple sclerosis. Eye (Lond). 2016;30(3):456–462., Epub 2015 Dec 18. PMID: 26681148; PMCID: PMC4791705. doi: 10.1038/eye.2015.256.
  • Grzybowski A, Barboni P. OCT and imaging in Central nervous system Diseases -The eye as a window to the brain. 2nd ed. Switzerland: Springer; 2020; p. 196–225. ISBN 978-3-030-26269-3
  • Araki S, Miki A, Goto K, et al. Macular retinal and choroidal thickness in unilateral amblyopia using swept-source optical coherence tomography. BMC Ophthalmol. 2017;17(1):167. doi: 10.1186/s12886-017-0559-3.
  • Ruan Y, Jiang S, Musayeva A, et al. Oxidative stress and vascular dysfunction in the retina: therapeutic strategies. Antioxidants (Basel). 2020;9(8):761. Published 2020 Aug 17. doi: 10.3390/antiox9080761.
  • Nishimura Y, Hara H, Kondo M, et al. Oxidative stress in retinal diseases. [Editorial]. Oxid Med Cell Longev. 2017;2017:4076518. doi: 10.1155/2017/4076518.
  • Yilmaz H, Ersoy A, Icel E. Assessments of vessel density and foveal avascular zone metrics in multiple sclerosis: an optical coherence tomography angiography study. Eye (Lond). 2020;34(4):771–778. doi: 10.1038/s41433-019-0746-y.
  • Murphy OC, Kalaitzidis G, Vasileiou E, et al. Optical ­coherence tomography and optical coherence tomography angiography findings after optic neuritis in multiple sclerosis. Front Neurol. 2020;11:618879. doi: 10.3389/fneur.2020.618879.
  • Farci R, Carta A, Cocco E, et al. Optical coherence tomography angiography in multiple sclerosis: a cross-sectional study. PLoS One. 2020;15(7):e0236090. Published 2020 Jul 23. doi: 10.1371/journal.pone.0236090.
  • Kleerekooper I, Houston S, Dubis AM, et al. Optical ­coherence tomography angiography (OCTA) in multiple sclerosis and neuromyelitis optica spectrum disorder. Front Neurol. 2020;11:604049. Published 2020 Dec 10. doi: 10.3389/fneur.2020.604049.
  • Fossarello M, Napoli PM, Farci R. Optical coherence ­tomography angiography in multiple sclerosis: a prospective study. Invest Ophthalmol Vis Sci. 2019;60(9):4560.
  • Boschetti NV, Smith JL, Osher RH, et al. Fluorescein ­angiography of optociliary shunt vessels. J Clin Neuroophthalmol. 1981;1(1):9–30.
  • Spain R, Liu L, Zhang X, et al. Optical coherence tomography angiography enhances the detection of optic nerve damage in multiple sclerosis. Br J Ophthalmol. 2018;102(4):520–524. doi: 10.1136/bjophthalmol-2017-310477.
  • Cordon B, Vilades E, Orduna E, et al. Angiography with optical coherence tomography as a biomarker in multiple sclerosis. PLoS One. 2020;15(12):e0243236. doi: 10.1371/journal.pone.0243236.
  • Wang X, Jia Y, Spain R, et al. Optical coherence tomography angiography of optic nerve head and parafovea in multiple sclerosis. Br J Ophthalmol. 2014;98(10):1368–1373. doi: 10.1136/bjophthalmol-2013-304547.
  • Jaumandreu L, Muñoz-Negrete FJ, Rebolleda G. Foveal avascular zone (FAZ) assessment with optical coherence angiography in patients with multiple sclerosis. Eye (Lond). 2021;35(4):1272–1273. doi: 10.1038/s41433-020-1030-x.
  • Ashtari F, Ataei A, Kafieh R, et al. Optical coherence tomography in neuromyelitis optica spectrum disorder and multiple sclerosis: a population-based study. Mult Scler Relat Disord. 2021;47:102625. doi: 10.1016/j.msard.2020.102625.
  • Pillay G, Ganger A, Singh D, et al. Retinal nerve fiber layer and ganglion cell layer changes on optical coherence tomography in early multiple sclerosis and optic neuritis cases. Indian J Ophthalmol. 2018;66(1):114–119. doi: 10.4103/ijo.IJO_539_17.
  • Vabanesi M, Pisa M, Guerrieri S, et al. In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis. Sci Rep. 2019;9(1):10371. doi: 10.1038/s41598-019-46251-3.
  • Khandelwal D, Dadarwal K, Hiremath A, et al. Role of optical coherence tomography in determining specific diagnostic pattern of retinal nerve fiber layer involvement in various Central nervous system demyelinating diseases: an observational study. Neurology Clinical Neurosc. 2021;9(5):376–380. doi: 10.1111/ncn3.12528.
  • Liu C, Xiao H, Zhang X, et al. Optical coherence ­tomography angiography helps distinguish multiple sclerosis from AQP4-IgG-seropositive neuromyelitis ­optica spectrum disorder. Brain Behav. 2021;11:e02125.
  • Irvine AR, Shorb SR, Morris BW. Optociliary veins. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83(3 Pt 1):OP541–6.
  • Harris A, Ishii Y, Chung HS, et al. Blood flow per unit retinal nerve fibre tissue volume is lower in the human inferior retina. Br J Ophthalmol. 2003;87(2):184–188. doi: 10.1136/bjo.87.2.184.
  • Tomita R, Iwase T, Ueno Y, et al. Differences in blood flow between superior and inferior retinal hemispheres. Invest Ophthalmol Vis Sci. 2020;61(5):27. doi: 10.1167/iovs.61.5.27.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.